PROS1 and COVID-19: These results indicated that the proinflammatory mediators could be stimulated by S protein interaction with immune and endothelial cells and that the SARS-CoV-2 virus infection may differentially activate host cells independently, which potentially explain the variety of clinical phenotypes and severity progress of COVID-19.